21 CFR 1306.07 - Administering or dispensing of narcotic drugs

Cite as21 CFR 1306.07
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
25 practice notes
  • Farmacia Yani; Decision and Order
    • United States
    • Federal Register May 20, 2015
    • May 20, 2015
    ...1301.28), 21 CFR 1306.05(a) (requiring that such prescription include either the prescriber's X number or a good faith statement), and 21 CFR 1306.07 (allowing a practitioner to administer, dispense or prescribe a Schedule III through V drug specifically approved by FDA for use in maintenan......
  • T.J. Mcnichol, M.D.; Decision and Order
    • United States
    • Federal Register September 17, 2012
    • September 17, 2012
    ...for treatment,'' may not administer more than ``one day's medication at a time,'' and may not do so ``for more than three days.'' 21 CFR 1306.07. Thus, contrary to the ALJ's understanding, there is nothing positive in Respondent's decision to prescribe 150 tablets of oxycodone 30mg (as well......
  • Hatem M. Ataya, M.D.; Decision and Order; Introduction and Procedural History
    • United States
    • Federal Register February 18, 2016
    • February 18, 2016
    ...for the purpose of relieving acute withdrawal symptoms when necessary while arrangements are being made for referral for treatment.'' 21 CFR 1306.07(b). This is so even when the physician ``is not specifically registered to conduct a narcotic treatment program.'' Id. However, the physician ......
  • U.S. v. Hayes, No. 84-1276
    • United States
    • United States Courts of Appeals. United States Court of Appeals (9th Circuit)
    • May 9, 1986
    ...the existence of a medical complaint and the appropriateness of treatment." The instruction, however, properly states the law. See 21 C.F.R. Sec. 1306.07(c) (1985). If a patient were a narcotic addict and the only medical complaint was addiction or withdrawal, Hayes could not have issued th......
  • Request a trial to view additional results
9 cases
  • U.S. v. Hayes, No. 84-1276
    • United States
    • United States Courts of Appeals. United States Court of Appeals (9th Circuit)
    • May 9, 1986
    ...the existence of a medical complaint and the appropriateness of treatment." The instruction, however, properly states the law. See 21 C.F.R. Sec. 1306.07(c) (1985). If a patient were a narcotic addict and the only medical complaint was addiction or withdrawal, Hayes could not have issued th......
  • United States v. Ilayayev, Nos. 05–CR–836
    • United States
    • United States District Courts. 2nd Circuit. United States District Court (Eastern District of New York)
    • August 5, 2011
    ...drugs to persons with intractable pain in which no relief or cure is possible or none has been found after reasonable efforts.” 21 C.F.R. § 1306.07(c). Still, the federal government, through the CSA and the DEA's regulations, imposes significant limitations on who can issue and fill opioid ......
  • Kerns v. Hoppe, No. 55615.
    • United States
    • Nevada Supreme Court of Nevada
    • March 21, 2012
    ...central nervous system depressant—OxyContin—in violation of state and federal law and without adequate monitoring and supervision. See 21 C.F.R. § 1306.07 (stating that in order for a practitioner to prescribe methadone to an addict without obtaining a DEA registration, the practitioner mus......
  • U.S. v. Cap Quality Care, Inc., Civil No. 05-163-P-H.
    • United States
    • U.S. District Court — District of Maine
    • May 2, 2007
    ...prescribing any Schedule II narcotic controlled drugs for maintenance or detoxification treatment."). 3. The government's brief cites 21 C.F.R. § 1306.07., a regulation that only indirectly supports the prohibition. Pl.'s Partial Objection to the Recommended Dec. (Docket Item 165) at 4 ('Pl......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT